Lori Arlinghaus, Ph.D.Associate Director of the Human Imaging Core
Imaging Research Scientist
My research interests are primarily focused on the translation of quantitative MR methods to the clinical cancer setting.
I am currently working on the development and improvement of quantitative MRI methods (at 3T) for use in treatment assessment in breast cancer. These methods include diffusion-weighted imaging (DWI) and magnetization transfer (MT) imaging.
Bane O, Hectors S, Wagner M, Arlinghaus LR, et al. Accuracy, repeatability and interplatform reproducibility of T1 quantification methods used for DCE-MRI: results from a multicenter phantom study. Magn Reson Med 2018 May;79(5):2564-2575
Griesenauer RH, Weis JA, Arlinghaus LR, Meszoely IM, Miga MI. Breast tissue stiffness estimation for surgical guidance using gravity-induced excitation. Phys Med Biol 2017;62(12):4756-4776.
Whisenant JG, Dortch RD, Grissom W, Kang H, Arlinghaus LR, Yankeelov TE. Bloch-Siegert B1-Mapping Improves Accuracy and Precision of Longitudinal Relaxation Measurements in the Breast at 3 T. Tomography 2016;2(4):250-259
Arlinghaus LR, Dortch RD, Whisenant JG, Kang H, Abramson RG, Yankeelov TE. Quantitative Magnetization Transfer Imaging of the Breast at 3.0 T: Reproducibility in Healthy Volunteers. Tomography 2016;2(4):260-266.